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Abstract
We present here the characterisation of the Leishmania small G protein ADP-Ribosylation Factor-Like protein 1 (ARL-1). The
ARL-1 gene is present in one copy per haploid genome and conserved among trypanosomatids. It encodes a protein of
20 kDa, which is equally expressed in the insect promastigote and mammalian amastigote forms of the parasite. ARL-1
localises to the Trans-Golgi Network (TGN); N-terminal myristoylation is essential for TGN localisation. In vivo expression of
the LdARL-1/Q74L and LdARL-1/T51N mutants (GTP- and GDP-bound blocked forms respectively) shows that GDP/GTP
cycling occurs entirely within the TGN. This is contrary to previous reports in yeast and mammals, where the mutant empty
form devoid of nucleotide has been considered as the GDP-blocked form. The dominant-negative empty form mutant
LdARL-1/T34N inhibits endocytosis and intracellular trafficking from the TGN to the Lysosome/Multivesicular Tubule and to
the acidocalcisomes; these defects are probably related to a mislocalisation of the GRIP domain-containing vesicle tethering
factors which cannot be recruited to the TGN by the cytoplasmic LdARL-1/T34N. Thus, besides the functional
characterization of a new mutant and a better understanding of ARL-1 GDP/GTP cycling, this work shows that Leishmania
ARL-1 is a key component of an essential pathway worth future study.
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Introduction
Leishmania sp are flagellated trypanosomatid parasites responsible
for widespread diseases in tropical and subtropical countries (http://
www.who.int/tdr/diseases/leish/default.htm). The parasite alter-
nates between a flagellated extracellular form in the insect guts and
an aflagellated intracellular form living in the parasitophorous
vacuoles of mammalian macrophages. Such particularities and the
evolutionary distance make it likely that there are sufficient
differences in the biological pathways between parasites and hosts
to find new parasite-specific drug targets. This is seriously needed
due to the limited choice of available treatments, which are old, and
the spreading of drug resistance. Basic research, accompanied by the
recent publication of the complete genome sequence of several
trypanosomatid species, including Leishmania [1,2], may help to find
new approaches to control these diseases.
Intracellular traffic is an essential process in all living organisms.
In humans, a number of severe diseases are caused by trafficking
deficiencies [3]. It is not absurd to expect to find within such
complex machinery a parasite-specific step that is exploitable to
impair parasite traffic and viability. To our knowledge, such an
achievement has not yet been reached, and it is much too early to
know whether and when therapeutic applications may arise.
However, there are already parasite-specific pathways candidates,
for example the now well studied trafficking of GPI-anchored
proteins in trypanosomes [4].
Vesicles represent the main tool of intracellular traffic and a great
number of proteins are involved in their assembly, mobility and
disassembly, including notably small G proteins, like members of the
ARF/ARL (ADP-Ribosylation Factor/ADP-Ribosylation factor-
Like) family [5–8]. There are 5 or 6 different ARFs and about a
dozen ARLs among this family, depending on the species. The most
studied are ARF-1 and ARF-6 with orthologues in yeast, plants,
mammals [9], and even protozoa like Leishmania [10] and
Trypanosoma [11,12]. ARL-1 has recently received much attention
and orthologues have been studied in several species. ARL-1 has
been localised to the trans-Golgi network (TGN) in yeast, mammals
[13,14] and T. brucei [15]. Essential in Drosophila [16], ARL-1
maintains the integrity of the Golgi apparatus [15,17,18], and
controls the vesicle traffic and the vacuole formation in yeast [19–
21].Asformostother membersof thefamily,myristoylation ofitsN-
terminus is essential for its localisation and function [15,19,22,23].
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bound forms. In yeast, a nucleotide exchange factor, Ysl2p [24],
and a GAP (GTPase-activating protein), Gcs1p [25], have been
characterised; in mammals, only a yet uncharacterised ARF-GAP
has been described [26]. Several effectors have been shown to
interact with the GTP-bound form of ARL-1 [14,18,27],
particularly the GRIP domain of several golgins/tethering factors.
In the current model, such interactions allow the recruitment of
these tethering factors to TGN membranes, which are essential for
the vesicular traffic between the Golgi apparatus and endosomes
[28–32]. This is probably how ARL-1 participates to the Golgi
apparatus maintenance and vesicular traffic.
Recently, remarkable studies with the orthologue TbARL-1
have been reported in Trypanosoma brucei. TbARL-1 is only
expressed in the bloodstream forms, where it is associated with
the Golgi apparatus; RNAi experiments showed that TbARL-1 is
essential for viability, Golgi apparatus maintenance and exocytosis
in bloodstream forms, but has no effect in insect forms [15]. As
Leishmania, this organism belongs to the Trypanosomatidae family.
However, the two genus diverged possibly more than 100 million
years ago [33] and they present many different features. To cite a
few, the percentage of G/C in the T. brucei genome is lower than in
L. major (41% versus 59.7% respectively) [34]; RNA interference
(RNAi) is functional in T. brucei but impossible in Leishmania and
concerning their life cycle, contrary to Leishmania, both T. brucei
insect and mammalian (or bloodstream) forms are flagellated and
extracellular, which has important physiological consequences.
We present here the characterisation of LdARL-1 in Leishmania.
Contrary to T. brucei, LdARL-1 is expressed in both the insect and
mammalian forms of the parasite. Design of a new mutant type,
LdARL-1/T51N, corresponding to the GDP-bound blocked form,
revealed that LdARL-1 cycles entirely within the TGN. This is
contrary to previous data obtained in yeast and mammals with
another mutant wrongly considered as the GDP-bound blocked
form,. Expression of the dominant-negative mutant LdARL-1/
T34N had severe inhibitory effects on intracellular traffic, showing
LdARL-1 involvement in the control of endocytosis, in intracel-
lular trafficking from the TGN to the Lysosome/MVT (Multive-
sicular tubule) and the acidocalcisomes, and in the TGN targeting
of the tethering factor pGRIP-2, a yet uncharacterised Leishmania
GRIP domain-containing protein.
Results
Identification of the L. donovani ARL-1 gene
Compilation of the first two consensus motifs of the GTP-
binding site (GLDXAGKT, WDXGGQ) of human (Hs)ARFs
(Swissprot accession numbers: ARF-1, P32889; ARF-3, P16587;
ARF-4, P18085; ARF-5, P26437; ARF-6, P26438) and ARLs
(ARL-1, P40616; ARL-2, P36404; ARL-3, P36405; ARL-4,
P40617) allowed the design of two degenerated oligonucleotides
(G019/G020) and the PCR-amplification of 144 bp fragments
from L. donovani LSB-51.1 genomic DNA. Fragment 4020 showed
70% identity with HsARL-1 and produced, when used as probe on
Southern blots with L. donovani genomic DNA, a band pattern
compatible with the existence of only one gene (not shown).
Subsequent screening of the L. donovani LSB 51.1 genomic cosmid
library allowed the isolation of a cosmid containing the entire
LdARL-1 ORF (561 bp); this region was sequenced over 1896 bp
(Genbank AF187855 and AAF29899). Upstream of the ATG
codon, a 34 bp long polypyrimidine tract (2101 to 268) followed
by 5 AG dinucleotides (potential spliced-leader attachment sites)
[35] ascertained the potential functionality of this gene.
The predicted ARL-1 protein, which contains 187 amino acids
(20 833 Da, pI 5.24), displays 55% identity with the human HsARL-
1, 52% with yeast ScARL-1 and 50% with human HsARF-1 (Fig 1).
As for all ARFs/ARLs, the Glycine at position 2 is a potential
myristoylation site. The first three consensus motifs of the GDP/
GTP binding site (GxxxxGKT, DxxG, and NxxD) [36] are present
(Fig 1) while the fourth one (C/SA/xx) is less conserved as often
observed for ARFs/ARLs. The ability of the recombinant LdARL-1
to bind GTPcS has been described elsewhere [37].
The ARL-1 gene in trypanosomatids
ARL-1 orthologue genes exist in one copy per haploid genome
in the parasites genome database (GeneDB: http://www.genedb.
org/) for L. major (LmjF17.0070, 187 aa, 98% identity) (Fig 1), L.
infantum (LinJ17.0080, 100% identity), L. brasiliensis (LbrM17_
V2.0080, 189 aa, 93% identity) and T. brucei (Tb927.7.6230,
previously Tb07.2F2.550, annotated as TbARF-3, 190 aa, 72%
identity, [15]). After PCR-amplification, we determined the
sequence of L. amazonensis LaARL-1, which has 4 different amino
acids compared to L. donovani and the changes are conservative
(Fig 1). In the case of T. cruzi, there are two entries:
Tc00.1047053506513.60 with a similar length (190 aa) to
LdARL-1 and Tc00.1047053508919.60 with a 101 aa N-terminal
extension; the ARL-1 part of the second entry hass 3 different aa
from the first one and they both share 74% identity with LdARL-1.
Fig S1 shows the gene organization of the ARL-1 region in the
genomes of these trypanosomatids.
In vivo expression and subcellular localisation of ARL-1
A rabbit immune serum raised against the last 15 aa of LdARL-1
(underlined in Fig 1) allowed the detection of a unique 20 kDa band
in promastigote and amastigote extracts of two strains of L.
amazonensis, the BA125 strain (Fig. 2) and the LV79 strain (not
shown). The expression of ARL-1 was similar in both forms of the
parasite.
Untagged or GFP-fused LdARL-1 variants were expressed in L.
amazonensis promastigotes using the pTEX [38] or the pNUS-
GFPcH [39] vectors, respectively, both leaving the LdARL-1 N-
terminus free. These vectors remain episomal and allow the
expression of exogenous proteins. The abundance of the
exogenous protein depends on the episome copy number, which
can be manipulated within certain limits by the selective antibiotic
concentration in the culture medium, and might also vary from
cell to cell after unequal partitioning at mitosis. In this study,
identical data were obtained with the transfectants expressing
untagged or GFP-fused proteins.
Western blot analyses confirmed that the transfectants were
expressing the proteins of interest (Fig 2). The endogenous 20 kDa
LaARL-1 and a 48 kDa protein corresponding to LdARL-1-GFP
were observed. Although LdARL-1 and LdARL-1-GFP were
expressed at a higher level than the endogenous LaARL-1, this had
no significant effect on the in vitro growth rate of the transgenic cell
lines compared to parental cells (Fig S2).
Indirect immunofluorescence microscopy observations with the
anti-LdARL-1 antiserum revealed a spot in the vicinity of the
kinetoplast and the flagellar pocket (Fig 3A), strongly reminiscent of
the TGN localization reported for LdARF-1-GFP [10]. Promasti-
gotes expressing LdARL-1-GFP showed the same localisation
(Fig 3B, 4A); the green GFP signal was adjacent to the red one of
mRed-LdLpg-2signal,aGolgicisternaemarker[40] (Fig3B)and co-
localised with LdARF-1-mRed [10] (Fig 3C). Electron microscopy
confirmed the LdARL-1 TGN localisation (Fig 3D). In the ARL-1
sequence of L. donovani, L. amazonensis, L. major and T.brucei, the Golgi
localisation signal MXXE [41] present in HsARL-1, ScARL-1 and
HsARF-1 (Fig 1) is replaced by LXXE, likely functional according to
our IF (immunofluorescence) results.
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N-myristoylation is important for ARFs membrane binding and
biological activity [23]. The LdARL-1 Glycine 2 (Fig 1) is a
potential myristoylation site [5,42]. When both LdARL-1 and L.
major N-myristoyltransferase were coexpressed in E. coli, recombi-
nant LdARL-1 could indeed be myristoylated [43]. To test the
biological relevance of this myristoylation, we created the LdARL-
1/G2A (unMyr) mutant, which cannot be myristoylated, and
expressed in L. amazonensis promastigotes. As seen on western blots
(Fig 2), LdARL-1/G2A-GFP was expressed at a similar level as
native LdARL-1-GFP and the expression of the endogenous native
protein was unmodified. The in vitro growth of untagged LdARL-
1/G2A transfectants was comparable to the wild type cells (Fig
S2). Remarkably, fluorescence microcopy analyses showed that,
unlike the native LdARL-1-GFP, LdARL-1/G2A-GFP remained
diffuse within the cytoplasm, including the flagellum, within 100%
of the cells (Fig 4B). Thus, like in other organisms, LdARL-1 must
be N-myristoylated for its correct targeting to the TGN.
LdARL-1 GDP/GTP cycling
G proteins cycle between GDP- and GTP-bound forms.
Functional studies of these proteins have been done using mutants
representing «GDP-bound» blocked (GDP to GTP exchange
deficient) or «GTP-bound» blocked (GTPase-deficient) forms. The
most recent characterisation of such mutants concerns human
HsARF-6 [44]: the Q67L mutant represents the GTP-bound
blocked form, T44N the GDP-bound blocked form, and the
T27N, an empty form devoid of nucleotide, earlier erroneously
considered as a GDP-bound form. The empty form of the native
protein is a transient intermediate bound to the nucleotide-exchange
factor; since the T27N mutant cannot bind GTP, the complex is
Figure 2. Expression of LdARL-1 and mutants in L. amazonensis.
Extracts of 3.10
6 exponentially growing L. amazonensis promastigotes
(about 3 mg of proteins) were submitted to western blot analysis using
the rabbit anti-LdARL-1 C-terminus immune serum (1:5000 dilution);
color was developed with an anti-rabbit IgG peroxidase conjugate
(1:10000 dilution) and an ECL revelation kit (Amersham). Internal
standard: 37 kDa LACK antigen. Left, negative control without anti-
LdARL-1 antiserum. Additional bands are revealed when the GFP-fused
proteins are expressed, probably due to partial degradation when the
cells were lysed, in spite of the presence of antiproteases (see Methods).
doi:10.1371/journal.pone.0001620.g002
Figure 1. Sequence analysis of ARL-1/ARF-1 of various species. Consensus motives for the GDP-GTP binding site are boxed in black. Mutated
and amino acids of interest are boxed in grey. The sequence of the C-terminal peptide synthesised for the production of the rabbit immune serum is
underlined. Databanks accession numbers: LdARL-1, Genbank AF187855 and AAF29899; LaARL-1, GenBank XXX; LmARL-1, GeneDB LmjF17.0070
(http://www.genedb.org/); TbARL-1, Genbank AAX70381, GeneDB Tb927.7.6230, previously Tb07.2F2.550; HsARL-1, Swissprot P40616; ScARL-1:
Genbank S46035; HsARF-1: Swissprot P32889; HsARF-6: Genbank NP_001654.
doi:10.1371/journal.pone.0001620.g001
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the available nucleotide-exchange factor becomes complexed.
Untagged proteins or GFP fusions of the three corresponding
mutants, LdARL-1/Q74L (GTP-bound blocked), /T51N (GDP-
bound blocked) and /T34N (empty) were created and stably
expressed in L. amazonensis promastigotes; similar data were
obtained for both series.
The growth rate of the cell lines expressing LdARL-1/Q74L or
LdARL-1/T51N were comparable (Fig S2). Both proteins localised
to the TGN (Fig 5A and D) and colocalised with the TGN marker
LdARF-1-mRed (Fig 5B/5C and 5E/5F, respectively). Remarkably,
while expressed at similar levels as LdARL-1/Q74L-GFP (Fig 2), the
double-mutant LdARL-1/G2AQ74L-GFP remained cytoplasmic
(not shown), as did LdARL-1/G2A-GFP, thus confirming that
myristoylation is mandatory for the TGN localisation.
The expression of LdARL-1/T34N-GFP provided different
observations. First, despite the comparable amount of endogenous
LaARL-1 between the different transgenic cell lines, LdARL-1/
T34N-GFP expression level was much lower compared to the
other variants (Fig 2). Accordingly, fluorescence microscopy
observations revealed that, unlike the other mutants, only 15-
20% of the cells were expressing detectable levels of LdARL-1/
T34N-GFP, suggesting that the protein was somehow toxic, and
its expression repressed or counterselected. However, the growth
rate of this cell line was comparable to the wild type cells (Fig S2).
Second, the fluorescence labelling obtained in the LdARL-1/
T34N-GFP-expressing cells was non-homogeneously distributed
throughout the cytoplasm and totally excluded from the flagellum
(Fig 5G), an observation easily discernable from the one made
previously with the G2A mutant (Fig 4B). This is consistent with
the TGN disorganisation observed in mammals with the
equivalent ARL-1/T31N mutant overexpression [18]. However,
the unchanged localisation of LdARF-1-mRed (Fig 5H) suggests
differences in TGN targeting/organisation. Finally, localization of
the double-mutant LdARL-1/G2AT34N (not shown) was un-
distinguishable from the G2A mutant, confirming again the
necessity of N-terminal myristoylation.
In summary, LdARL-1 entire GDP/GTP cycling occurs within
the TGN; the empty form is cytoplasmic.
LdARL-1 and intracellular trafficking
The various LdARL-1 mutants were used to further explore
LdARL-1 function. As the TGN is a complex structure specialised
in the sorting of molecules to the plasma membrane, the lysosome
and other organelles, the putative involvement of LdARL-1 in
intracellular traffic was investigated.
a/Exocytosis and endocytosis. The trypanosomatids are
polarised cells in which endo- and exocytosis occur solely in a
peculiar structure, the flagellar pocket. Upon exogenous expression
of LdARL-1/T34N-GFP (empty), the flagellar pocket of the
transgenic L. amazonensis cells appeared inflated, forming a gap at
the anterior part of the cells (Fig 5G, fp); this was better resolved by
labelling the pellicular and pocket membranes with Texas-Red-
Concanavalin A, as seen for the cell pictured on Fig 6D–G and
comparing to a cell expressing native LdARL-1-GFP (Fig 6A) or
LdARL-1/T51N-GFP (GDP) (Fig 6B–C). This flagellar pocket
inflation was similar to the observation made when endocytosis was
inhibited by RNAi ablation of clathrin heavy chain in T. brucei [45],
but could also result from enhanced exocytosis.
The activity of the secreted acid phosphatase (SAP) was
determined in the culture medium of untransformed cells and
expressing native or mutated LdARL-1-GFP; no significant
difference was found (Fig S2), suggesting that SAP exocytosis
was unmodified.
Figure 3. LdARL-1 subcellular localisation in L. amazonensis
promastigotes. A. IF on fixed cells: A1, phase contrast; A2, co-labelling
with DAPI (blue) and FITC-anti rabbit-IgG plus anti-LdARL-1 rabbit
immune serum (green). B. IF on fixed cells co-transformed with pNUS-
LdARL-1-GFPcH (green) and pNUS-mREDnD-LdLPG-2 (red) plus DAPI
staining (blue). C. IF on fixed cells co-transformed with pNUS-LdARL-1-
GFPcH (C1, green) plus pNUS-LdARF-1-mRedcD (C2, red), overlay (C3).
D. EM of cells transformed with pNUS-LdARL-1-GFP and incubated with
anti-LdARL-1 immune serum. C1 and C2 are sections of two different
cells. Black dots (10 nm gold particles) show the LdARL-1 immunore-
active spots. N: nucleus; G: Golgi apparatus; K: kinetoplast; F: flagellum;
FP: flagellar pocket.
doi:10.1371/journal.pone.0001620.g003
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(Fig 7). In Leishmania, this dye is readily internalised and targeted
through endosomes to the final digestive compartment termed
Lysosome/Multivesicular Tubule (MVT) [46]. In cells expressing
LdARL-1-GFP (Fig 7A–D), LdARL-1/Q74L-GFP (not shown) or
LdARL-1/T51N-GFP (not shown), FM4-64 endocytosis occurred as
expected, with a progressive and massive FM4-64 labelling from the
flagellarpockettotheMVTfrom0to120 minutes.Onthecontrary,
cells expressing LdARL-1/T34N-GFP showed endocytosis defect
(Fig 7E–H); the FM4-64 uptake was blocked, the labelling,
remaining in the area of the flagellar pocket up to 60 minutes
(Fig 7E–G, arrows), was only seen progressing to the MVT at later
times (120 min) and in much smaller amounts (Fig 7H, arrow); as
comparison, the cell a in Fig 7F, which expresses LdARL-1/T34N-
GFP, and the cell b which does not stresses the difference in FM4-64
internalization. This endocytosis defect was not due to clathrin
depletion, as revealed by immunofluorescence with an anti-
TbClathrin Heavy Chain immune serum (not shown).
b/Traffic to the lysosome/MVT. To further investigate the
endocytosis deficiency observed in the LdARL-1/T34N-GFP-
Figure 4. Localisation of the non-myristoylated LdARL-1. Fixed L. amazonensis promastigotes transformed with: A, pNUS-LdARL-1-GFPcH
(green); B, pNUS-LdARL-1/G2A-GFPcH (green).
doi:10.1371/journal.pone.0001620.g004
Figure 5. Localisation of LdARL-1-GFP mutants (GTP-, GDP-bound and empty forms). Fixed L. amazonensis promastigotes expressing in
red LdARF-1-mRed (5B, 5E, 5H) and in green LdARL-1/Q74L-GFP (GTP) (5A), LdARL-1/T51N-GFP (GDP) (5D), LdARL-1/T34N-GFP (empty) (5H); overlays
are in 5C, 5F and 5I. fp, flagellar pocket.
doi:10.1371/journal.pone.0001620.g005
The Leishmania ARL-1
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w a su s e da sm a r k e r( F i g8 ) .I nLeishmania, this membrane-anchored
protein enzyme, essential for the biosynthesis of glycophos-
phatidylinositol anchors of membrane proteins, localises to the
transitional Endoplasmic Reticulum [47]. However, GFP-DPMS
chimeras are transported, via the Golgi apparatus and multivesicular
bodies, to the lysosome/MVT [48]. A similar observation was made
withanmRed-DPMSchimerainourcellsexpressingnativeLdARL-
1-GFP (Fig 8A), LdARL-1/G2A-GFP (Fig 8B), LdARL-1/Q74L-
GFP (Fig 8C) and LdARL-1/T51N-GFP (Fig 8D). In contrast, the
mRed-DPMS chimera was undectectable in cells expressing the
empty form LdARL-1/T34N-GFP (Fig 8E); as shown on Fig 8E,
there is a clear mutual exclusion between the expression of LdARL-
1/T34N-GFP (cell a) and mRed-DPMS detection (cell b). This
suggests an alteration of the secretion pathway and/or a traffic
misdirection.
c/Traffic to the acidocalcisomes. In trypanosomatids,
acidocalcisomes are essential acidic organelles, probably
lysosome-related [49]. They contain polyphosphates and
calcium. Their acidic pH is maintained via the action of a
membrane-bound pump, the proton pyrophosphatase (VP1). In T.
brucei, TbVP1 is essential for the survival of the mammalian forms
of the parasite [50].
The VP1 orthologue exists in L. amazonensis (LaVP1) and can be
detected by immunofluorescence, using the anti-TbVP1 immune
serum (N. Bakalara, personal communication), within large round-
shaped organelles, distributed thoughout the promastigote body.
Using the TbVP1 antibody, this characteristic pattern of
acidocalcisomes was observed in L. amazonensis promastigotes
expressing LdARL-1-GFP (Fig 9A-1), LdARL-1/Q74L-GFP
(Fig 9A-2), LdARL-1/T51N-GFP (Fig 9A-3) and the deloca-
lised/inert LdARL-1/G2A-GFP (Fig 9A-4). Strikingly, in cells
expressing LdARL-1/T34N-GFP, TbVP1 was undetectable
(Fig 9A-5). However, DAPI staining of live cells, which allows
visualisation of their acidocalcisomes by revealing their polypho-
sphate content, showed that all cells expressing LdARL-1-GFP
(Fig 9B-1), LdARL-1/T34N-GFP (Fig 9B-2) and LdARL-1/T51N-
GFP (Fig 9B-3) contained polyphosphate/acidocalcisomes; this
ruled out the possible absence of these organelles in the LdARL-1/
T34N-GFP expressing cells. Therefore, in L. amazonensis, expres-
sion of LdARL-1/T34N-GFP induced a misdirection, possibly
exocytosis, of the membrane-bound proton pyrophosphatase.
LdARL-1 and GRIP domain proteins
In mammals and yeast, ARL-1/GTP has been shown to bind to
the GRIP domain of large coiled-coil proteins, a conserved C-
terminal sequence of about 45 residues sufficient to direct these
proteins to the TGN [51,52]. These proteins are vesicle tethering
factors [32]. In the Trypanosomatid genomes, only two proteins
are predicted to possess GRIP domains. We called them pGRIP-1
(L. infantum Linj11.0070 and L. major LmjF11.0070 with 1334
amino acids, T. brucei Tb11.02.5040 with 613 aa) and pGRIP-2 (L.
infantum LinJ34.3660 with 488 aa, L. major LmjF34.4090 with 435
aa and T. brucei Tb927.4.640 with 462 aa). They share homologies
solely in the GRIP domains (within trypanosomatids and other
species). We isolated the L. donovani GRIP domain of pGRIP-1
(called LdGRIP), its T.brucei homologue (TbGRIP, which allowed
the TGN targeting of the GFP-TbGRIP fusion protein in L.
Figure 6. LdARL-1 and the flagellar pocket. Fixed L. amazonensis promastigotes with plasma membrane labelled in red with Concanavalin A-
Texas Red. A, cell expressing in green LdARL-1-GFP. B-C, cell expressing in green LdARL-1/T51N-GFP (GDP); D-F, cell expressing in green LdARL-1/
T34N-GFP (empty). The yellow signal is an overlay of green and red signals.
doi:10.1371/journal.pone.0001620.g006
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three ORFs were fused with mRed at their N-terminus, leaving the
GRIP domain at the C-terminus, and co-expressed in L.
amazonensis together with LdARL-1-GFP or its mutants. As the
results obtained were similar, only the data obtained with mRed-
LdpGRIP-2 will be described.
Fluorescence microscopy analyses revealed that mRed-
LdpGRIP-2 co-localised to the TGN with LdARL-1-GFP
(Fig 10A), LdARL-1/Q74L-GFP (Fig 10B), and LdARL-1/
T51N-GFP (Fig 10D). Interestingly, LdARL-1/G2A-GFP, which
remained cytoplasmic (cf Fig 4B, 6C), did not interfere with
mRed-LdpGRIP-2 localisation (Fig 10C). Even more interestingly,
LdARL-1/T34N-GFP inhibited the TGN addressing of mRed-
LdpGRIP-2, as both proteins colocalised within the cytoplasm
(Fig 10E). This observation is consistent with the TGN
disorganisation observed in mammals by the equivalent mutant
ARL-1/T31N overexpression [18] and probably explains the
interruption of intracellular traffic from the TGN, since the vesicle
tethers are no longer recruited to their location.
Discussion
1. The LdARL-1 gene in Leishmania and other
Trypanosomatids
We identified and characterised a trypanosomatid member of
the ARF/ARL family, the Leishmania LdARL-1. The gene was
named ARL-1 after the highest percentage of identity with the
corresponding mammalian and yeast homologues. It is conserved
in other Leishmania (L. infantum, 100% identity; L. major, 3 amino
acids are different; L. amazonensis, 4 amino acids are different; L.
brasiliensis, 12 amino acids are different, one is added) and
trypanosome species (T. brucei, 47 amino acids are different, 3 are
added) whose sequence is available.
The situation in T. cruzi might be different as two sequences
were reported. The first TcARL-1 has a comparable size to other
species (45 different amino acids, 3 added). The second TcARL-1
has a 101 amino acid N-terminal extension; its ARL-1 domain has
3 different amino acids when compared to the first TcARL-1; 46
different amino acids, 3 added when compared to LdARL-1.
Figure 7. LdARL-1 and FM4-64 internalisation. L. amazonensis promastigotes expressing LdARL-1-GFP (A–D, green) or LdARL-1/T34N-GFP
(empty) (E–H, green) were incubated at 24uC for 15 min with 2 mg/ml FM4-64FX (red), washed and further incubated for 0 min (A, E), 15 min (B, F),
60 min (C, G) and 120 min (D, H) before fixation; fp, flagellar pocket; MVT, Lysosome/Multivesicular Tubule. Colocalization of red and green results in
a yellow signal.
doi:10.1371/journal.pone.0001620.g007
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T in a stretch of 7 in the vicinity of the 59 side of the ARL-1 part.
There is no obvious polypyrimidine tract upstream of the ATG
and the predicted extended TcARL-1 protein cannot be N-
myristoylated because of the absence of a Glycine in position 2.
Although there is an example in mammals of a chimeric protein
with a C-terminal ARF-1 part and a N-terminal extension playing
the role of an internal GAP (GTPase Activating protein) [54], the
reality of the T. cruzi variant should be investigated in more detail
to rule out the possibility of sequencing errors and/or to relate it
with the existence of two divergent lineages of T. cruzi [55],
eventually compatible with a 3 amino acid difference between the
two TcARL-1 regions.
Conservation of the general organisation of the chromosomal
region (Fig S1) (even for the extended variant gene of T. cruzi) and
the comparable percentages of identity between the different
neighbouring orthologues across species suggest that all ARL-1s
are functional homologues and that the TbARL-1 gene [15],
erroneously annotated as TbARF-3 (GeneDB http://www.gen-
edb.org/) should be renamed TbARL-1, unless functional data
contradict this assumption.
2. N-myristoylation of LdARL-1
As for other members of the ARF/ARL family, the glycine in
position 2 represents a myristoylation site; myristoylation is
impossible for the LdARL-1/G2A-GFP mutated protein which
remained diffuse within the cytoplasm, including the flagellum. Still,
themRed-LdpGRIP-2,mRed-LdGRIPormRedTbGRIPlocalisedto
the TGN, showing that the LdARL-1/G2A-GFP was unable to
compete with the endogenous native LaARL-1 and inhibit its
function. Emphasising the essential character of myristoylation, the
double-mutants LdARL-1/G2AQ74L-GFP (unMyr-GTP) and
LdARL-1/G2AT34N-GFP (unMyr-empty) remained cytoplasmic,
and their expression had no effect on the GRIP domain protein
targeting. The absence of N-terminal myristate probably generates
functionally inert LdARL-1 proteins, unable to bind to membranes
and be recognised by a putative membrane bound targeting
receptor/mechanism as suggested for HsARF-6 [56].
3. The LdARL-1 mutants and GDP/GTP cycling
Based on ras protein properties, mutations of conserved amino
acids have been created to mimick GDP-bound or GTP-bound
forms of the proteins of this superfamily. Thus, the last Threonine
of the first motif of the GTP binding site (Fig 1) has been
considered essential for GTP binding, its mutation leading to a
drastic decrease in GTP affinity, hence producing a GDP-bound
blocked form. However, due to the difficulties of determining the
affinities for nucleotides, especially when they are low and if the
proteins are insoluble, these affinities have been rarely looked over.
After the crystal structure of several GDP- or GTP-bound ARF/
ARLs has been solved, the validity of the prediction for all the ras
family proteins became questionable. In a recent detailed study of
human ARF-6 [44], it was clearly shown that the mutant ARF-6/
T27N, considered as a GDP-bound blocked form, was in reality
Figure 8. LdARL-1 and Golgi to Lysosome/MVT traffic. BA125 L. amazonensis promastigotes expressing in red the mRed-DPMS and in green
LdARL-1-GFP (A), LdARL-1/G2A-GFP (unMyr) (B), LdARL-1/Q74L-GFP (GTP) (C), LdARL-1/T51N-GFP (GDP) (D) or LdARL-1/T34N-GFP (empty) (E).
doi:10.1371/journal.pone.0001620.g008
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interacted with both GDP and GTP. Accordingly, in our work, the
mutant LdLdARL-1/T34N was considered as an empty form, and
the new mutant LdARL-1/T51N, a GDP-blocked form (cf Fig S3).
When expressed in Leishmania promastigotes, LdARL-1/T34N-
GFP was delocalised to the cytoplasm, similarly to the equivalent
mutants in mammalian cells [18]. However, LdARF-1-mRed
localisation did not change, so that the TGN was not disorganised
to the same extent as in mammals [18]. accordingly, it has been
shown in mammals that Brefeldin A-induced disorganisation of
the Golgi, which includes ARF-1 delocalisation to the cytoplasm,
occurs within minutes of drug exposure, while it takes much longer
for ARL-1 [17]. We found no effect of Brefeldin A in Leishmania
(unpublished data), possibly because it was not internalised.
Conversely, LdARL-1/T51N-GFP (GDP) localised to the TGN,
and co-localised with LdARF-1-mRed. It was the same for LdARL-
1/Q74L-GFP (GTP), which was different from mammals, where
ARL-1/Q71L (GTP) led to an expansion of the Golgi and a
delocalisation of ARF-1 [18]. It then appears that, in Leishmania,
the entire LdARL-1 GDP/GTP cycling occurs within the TGN
and the delocalisation to the cytoplasm of the «empty form» is a
non-physiological event due to the expression of a transient form
normally associated to the nucleotide exchange factor; the blocked
empty form might act as a sink for the nucleotide exchange factor,
thus forming a stable and inactive complex, as has been suggested
for the equivalent mutant ARF-1/T31N [57].
Figure 9. LdARL-1 and acidocalcisomes. A. Fixed L. amazonensis promastigotes expressing in green LdARL-1-GFP (1), LdARL-1/Q74L-GFP (GTP)
(2), LdARL-1/T51N-GFP (GDP) (3), LdARL-1/G2A-GFP (unMyr) (4) or LdARL-1/T34N-GFP (empty) (5) and stained in red with the rabbit anti-TbVP1
(acidocalcisomes marker) immune serum plus anti-rabbit IgG-Texas-Red conjugate. B. Live L. amazonensis promastigotes expressing in green LdARL-
1-GFP (1-2), LdARL-1/T34N-GFP (empty) (3-4) or LdARL-1/T51N-GFP (GDP) (5-6) and stained with DAPI: in Blue, nucleus and kinetoplast, in yellow:
polyphosphates of acidocalcisomes [50].
doi:10.1371/journal.pone.0001620.g009
The Leishmania ARL-1
PLoS ONE | www.plosone.org 9 February 2008 | Volume 3 | Issue 2 | e1620From our data, one can predict that the unknown exchange
factor is limiting, since the mutant LdARL-1/T34N-GFP is
dominant-negative, i.e. blocks the endogenous native LaARL-1
function. The lack of physiological effect of LdARL-1/T51N-GFP
suggests that this form does not stably associate with the exchange
factor, the interaction being stabilised by the release of GDP. On
the contrary, the unknown GAP is either non-limiting or not
blocked by LdARL-1/Q74L-GFP since expression of this mutant
does not block the endogenous native ARL-1 function. There is no
obvious Ysl2p homologue in the Leishmania genome, the suggested
yeast Arl-1p nucleotide exchange factor [24], nor Gcs1p, the
suggested Arl-1p GTPase-activating protein [25]; their identifica-
tion might help to better understand LdARL-1 GDP/GTP cycling.
These data illustrate the diversity of ARL proteins modes of
GDP/GTP cycling. If one compares LdARL-1 and LdARL-3A
[58,59], LdARL-1/GDP- or /GTP-blocked expression does not
impair the endogenous protein function, while LdARL-3A/GDP- or
/GTP-blocked expression blocks the endogenous La/LdARL-3A
function, resulting in a drastic flagellar shortening; on the other
hand, LdARL-1/T34N (empty) is dominant-negative whereas
LdARL-3A/T30N (empty) is inert. The most likely explanation for
these differences lies in the necessity (LdARL-1) or not (LdARL-3A)
ofa nucleotideexchange factor for the GDP/GTP cycle completion.
4. LdARL-1 role in intracellular traffic as revealed by the
dominant-negative mutant LdARL-1/T34N
Expression of LdARL-1/T34N-GFP significantly perturbed
Leishmania intracellular trafficking. Endocytosis was completely
blocked, trafficking of DPMS from the Golgi to the Lysosome/
MVT, and of the membrane-bound vacuolar proton pyrophos-
phatase to the acidocalcisomes, was interrupted. The fate of these
markers remains enigmatic; they were possibly degraded or
misdirected and exocytosed, which would be reminiscent of
ScArl-1 KO, where lucifer yellow uptake was reduced and the
vacuolar Carboxypeptidase Y secreted instead of being vacuolar
[21]. In Leishmania, exocytosis seemed unaffected; however, only
the SAP marker (secreted acid phosphatase) could be investigated
and changes changes in exocytosis might not have been detected
since only 15–20% of the cells expressed the mutated protein.
The acidocalcisomal defect observed with LdARL-1/T34N-
GFP expression resembled the vacuolar defect obtained in yeast
with the mutant Arl-1p/D151G mutant, which proved also
dominant-negative [20], but the mechanism of action is probably
different, because, from the protein structures, the D151 of Arl-1p
does not interact with GDP or GTP. At least some of the
membrane-bound proteins of acidocalcisomes originate from the
TGN and a functional LdARL-1 protein is essential for their
transport to their final compartment. Whether LdARL-1-mediated
targeting to acidocalcisomes is direct from the TGN or necessitates
endosomal/lysosomal intermediates remains unknown [49] and
might be investigated in the future if/when appropriate Leishmania
protein markers are identified.
5. ARL-1-dependent Golgi targeting of GRIP domain
containing Golgins
The GRIP domain is a C-terminal 45 aa long domain present in
at least five human and one yeast proteins [32,60]. Essential for the
TGN targeting of these proteins, it is conserved in trypanosoma-
tids and in Leishmania,aT. brucei GRIP domain is sufficient to
target GFP to the TGN [53].
Based on two-hybrid and affinity chromatography experiments,
it has been shown that the GTP-bound form of Scarl-1p (or
Figure 10. LdARL-1 and LdpGRIP-2. Overlay of fixed L. amazonensis promastigotes expressing in red mRed-LdpGRIP-2 and in green LdARL-1-GFP
(A), LdARL-1/Q74L-GFP (GTP) (B), LdARL-1/G2A-GFP (unMyr) (C), LdARL-1/T51N-GFP (GDP) (D) and LdARL-1/T34N-GFP (empty) (E). Overlay of red and
green is yellow.
doi:10.1371/journal.pone.0001620.g010
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(described in yeast but applicable to mammals), the GDP-bound
form of Scarl-1p (HsARL-1) is cytoplasmic; when GDP is
exchanged with GTP under the action of the nucleotide exchange
factor, Scarl-1p (HsARL-1) moves to the Golgi membranes and
recruits GRIP domain proteins [30] [61,62]. In this model, it has
been considered that the GDP form of Scarl-1p (HsARL-1) is
cytoplasmic, because the mutants Scarl-1p/T32N (HsARL-1/
T31N) mutants are cytoplasmic. It has also been assumed that the
GDP-loaded native Scarl-1p (HsARL-1) is equivalent to the Scarl-
1p/T32N (HsARL-1/T31N) mutant, which is probably inaccurate
if these mutants are «empty forms».
In Leishmania, there are two proteins with GRIP domains, which
we called LdpGRIP-1 and LdpGRIP-2. LdpGRIP-2 and the GRIP
domains of LdpGRIP-1 (LdGRIP) and TbpGRIP-1 (TbGRIP) were
fused to the C-terminus of the mRed protein: mRed-LdpGRIP-2
and mRed-LdGRIP/-TbGRIP co-localised with all LdARL-1
mutants, except the inert non-myristoylated one. More specifically,
mRed-LdpGRIP-2 and mRed-LdGRIP/-TbGRIP were de-local-
ised to the cytoplasm with LdARL-1/T34N-GFP. From our data,
LdARL-1/T51N-GFP is TGN-specific, while LdARL-1/T34N-
GFP is cytoplasmic. Since the «empty form» and GRIP domain
proteins probably do not interact physically, these cytoplasmic
localisations probably represent a common consequence of the
TGN destabilisation, whixh may not be complete since ARF-1-
mRed localisation did not change (within the limits of the
fluorescence micoscopy resolution).
At least for Leishmania, the model of ARL-1/GRIP domain
interaction and Golgi recruitment might be slightly modified.
GRIP domain proteins and ARL-1 under both GDP and GTP
forms are localised to the TGN. Both LdARL-1 forms are probably
associated to membranes as HsARF-6 [56]. The GTP form may
recruit GRIP-domain proteins from the Golgi soluble compart-
ment to Golgi membranes and the GDP form releases them. This
is consistent with the fact that in Brefeldin A-treated mammalian
cells, ARL-1 is delocalised from the Golgi membranes while GRIP
domain proteins are not [27], showing that, at least in mammals,
ARL-1 is not necessary for the maintenance of GRIP domain
proteins in the TGN. In the case of Arl1p knockout in yeast, the
GRIP domain protein Imh1p was mislocalised [29] possibly
because it could not reach the Golgi at all.
The recruitment of GRIP domain proteins to the Golgi also
requires the presence of another small G protein, Scarl3p, and an
integral membrane protein, ScSys1p [61,62]; Scarl3p/GTP and /
GDP forms were included in the study, but the mutant used for the
GDP form might also be an «empty form»; the model should be
revisited according to this new interpretation.
Concerning Leishmania, we have found a putative Scarl-3p
homologue (not yet functionnaly investigated), but there is no
obvious candidate for ScSys1p. Much work remains to be done for
the understanding of this aspect of the Golgi structure/function.
6. Significance of LdARL-1 in the biology of Leishmania
cells
The LdARL-1 gene is expressed in both promastigotes (insect
forms) and amastigotes (mammalian forms) of L. donovani and L.
amazonensis. This differs from T. brucei, where TbARL-1 is
expressed only in the bloodstream forms of the parasite (i.e. the
mammalian forms) and is essential for their viability, as revealed
by RNAi experiments [15]. Although it has not been formally
demonstrated and in spite of being annotated as ARF-3 in the T.
brucei database (Tb927.7.6230, GeneDB http://www.genedb.org/),
this TbARL-1 is very likely the functional homologue/orthologue of
LdARL-1 given the synteny of the homologous chromosomal region
of several trypanosomatids (Fig S1). The differential expression
seen in T . brucei forms probably reflects differences in the
physiology of these cells: endocytosis is minimal in T. brucei
insect forms, while it is extraordinarily active in bloodstream
forms [4], which correlates well with LdARL-1 involvement in
endocytosis. In Leishmania, LdARL-1 and endocytosis must be
active in all forms of the parasite.
Finally, the fact that LdARL-1 could not complement the yeast
arl-1D deletion mutant [21] (not shown) reveals that, even for
evolutionary conserved pathways such as intracellular traffic, inter-
species differences exist, which might hopefully be exploited
against deleterious (from the human point of view only) organisms
in the future.
Materials and Methods
Parasites, animals and immune sera
Promastigotes of L. donovani (MHOM/SD/00/Khartoum:
LSB51.1) and L. amazonensis (MHOM/BR/1987/BA125;
MPRO/BR/1972/M1841=LV79) were cultured at 24uCi n
AM medium [58,63]. Parental and transformed L. amazonensis
promastigotes growth was monitored everyday after seeding at a
density of 2,5610
6/ml by counting with a Malassez hemocytom-
eter. Balb/c mice (Centre d’Elevage Janvier) were infected in
footpads with 5 10
6 L. amazonensis promastigotes; amastigotes were
recovered from lesions as previously described [58].
An anti-LdARL-1 C-terminus rabbit immune serum was
prepared as described for LdARL-3A [58] using an LdARL-1 C-
terminal synthetic peptide (NH2-MDWLVERLREQGIGA-
COOH, Genosphere Biotech) and a «Fauve de Bourgogne»
rabbit (Centre d’Elevage Janvier). The rabbit anti-TbVP1 immune
serum has been described [50,64]. The rabbit anti-LACK immune
serum [65] was kindly provided by Dr J.-C. Antoine and the rabbit
anti-TbClathrin heavy chain immune serum [66] by Dr M. Field.
Protein extraction and western blotting were done as previously
described [58] except for the revelation, done with a rabbit anti
IgG peroxidase conjugate (1:10000 dilution) and an ECL
revelation kit (Amersham). The secreted acid phosphatase (SAP)
activity was determined as previously [58] according to [67].
Briefly, after seeding the cells at a density of 2.5 10
6 per ml,
aliquots of the culture medium were removed every following day
for 5 days, filtered through a 0.22 mm pores membrane to remove
cells and debris; 138 ml supernatant were then incubated in a final
volume of 200 ml with 50 mM sodium acetate pH 4, 0.1% b-
mercaptoethanol (v/v), 50 mM para-nitrophenyl phosphate for
30 min at 37uC; the reaction was stopped with 800 ml sodium
hydroxide 2 M and the absorbance of the released para-
nitrophenolate at 410 nm determined; the amount of para-
nitrophenolate ion was calculated considering an extinction
coefficient of 17.8 mM
21, and the data presented as nmoles
para-nitrophenyl phosphate hydrolyzed per minute and milliliter
of supernatant.
Isolation of the LdARL-1 gene
144 bp PCR fragments were amplified with oligonucleotides
G019 (59 GGIYTIGAYDVIGCIGCIAARAC 39)/G020 (59
YTGICCICCIAIRTCCCA 39) from L. donovani genomic DNA,
cloned into the pUC18 vector and sequenced. The 4020 fragment
was used as a probe to screen a set of filters of the L. donovani LSB-
51.1 genomic cosmid Stuartlab-Cos library (gift of Drs T. DeVos,
P. Myler and K. Stuart). The complete LdARL-1 ORF was
sequenced on cosmid nu7227, recovered with primers G039 (59
tgtggatcccatATGGGTGCGTGGCTGAC 39) /G043B (59 tgt
ggatcc GGTTGGCCAGGCGGTCA 39) and cloned into the
BamHI site of pBluescriptSK- (pORF-LdARL-1).
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For protein expression in L. amazonensis, two types of vectors
were used. The pTEX vector [38] confers G-418 resistance and
allows high protein expression. The pNUS series [39] allows
moderate expression of proteins fused either to the Green
fluorescent protein (GFP) at their C-terminus (pNUS-GFPcH,
conferring hygromycin resistance) or to the monomeric Red
fluorescent protein (mRFP [68]) at their N/C terminus (pNUS-
mREDnD/-cD conferring blasticidin resistance). All constructs
were sequenced prior Leishmania transfection.
The LdARL-1 ORF was recovered from pORF-LdARL-1 by
BamHI digestion and cloned into the pTEX vector at the BamHIs i t e
(pTEX-LdARL-1) and the pNUS-GFPcH vector between NdeIa n d
KpnI after PCR-amplification from pORF-LdARL-1 with primers
G039/G110 (59 tgtggtaccAGCACCGATCCCTTGCT 39)t o
generate pNUS-LdARL-1-GFPcH. The LdARL-1/G2A mutant
was created by PCR amplification from pORF-LdARL-1 with the
Mut5B (59 tgtggatcccatATGGCTGCGTGGCTGACA 39; C
represents the mutated nucleotide)/G043B primers, and cloned
into the pTEX and the pNUS-GFPcH as above, generating pTEX-
LdARL-1/G2A and pNUS-LdARL-1/G2A-GFPcH. The LdARL-
1/T34N mutant was created by site-directed mutagenesis of pORF-
LdARL-1, using oligonucleotides Mut6 (59 CCGATAGAGAATT-
GAATTCTTTCCCGC 39; T represents the mutated nucleotide)/
Mut8 (59 CAAAAGCTGGAGCCCCACCGCGGTGG 39; C
inactivates the vector SacI site) and the Transformer Site-Directed
Mutagenesis Kit (Clontech) according to manufacturer’s instruc-
tions, generating pORF-LdARL-1-T34N; the ORF was subsequent-
ly recloned into the pTEX and the pNUS-GFPcH as above (pTEX-
LdARL-1/T34N and pNUS-LdARL-1/T34N-GFPcH). The dou-
ble-mutant LdARL-1/G2AT34N was obtained by amplification
from LdARL-1-T34N with primers Mut5B/G110 and cloned into
the pNUS-GFPcH (pNUS-LdARL-1/G2AT34N-GFPcH) as above.
The LdARL-1/Q74L mutant was created by nested PCR
amplification from pORF-LdARL-1, using first oligonucleotides
G039/Q20B (59 TCGCACACCCGTTAGGCCGCCAAGGT-
CCC 39; A represents the mutated nucleotide) and Q20A (reverse
complement of Q20B)/G043B, then G039/G043B with a mixture
of both previously amplified fragments; the mutated ORF was then
recloned into pTEX and pNUS-GFPcH as above (pTEX-LdARL-
1/Q74L and pNUS-LdARL-1/Q74L-GFPcH). The double-mutant
LdARL-1/G2AQ74LwasobtainedbyamplificationfromLdARL-1-
Q74L with primers Mut5B/G040B (59 acaggatccTCACTAAG-
CACCGATCCCTTG 39) and cloned into the pNUS-GFPcH
(pNUS-LdARL-1/G2AQ74L-GFPcH) as above. The LdARL-1/
T51N mutant was created by nested PCR amplification from
pORF-LdARL-1, using first oligonucleotides G039/G287 (59
ACTCCCACATTGGGGACGGTG 39; T represents the mutated
nucleotide) and G286 (reverse complement of G287)/G110, then
G039/G110 with a mixture of both previously amplified fragments;
the mutated ORF was then recloned into the pNUS-GFPcH as
above (pNUS-LdARL-1/T51N-GFPcH) and into the pTEX at the
BamHI site after PCR amplification from pNUS-LdARL-1/T51N-
GFPcH with G039/G040B (59 acaggatccTCACTAAGCACC-
GATCCCTTG 39)(pTEX-LdARL-1/T51N). The LaARL-1 se-
quence has been dertermined after PCR amplification from L.
amazonensis genomic DNA with primers G222 (59 tatgcgcccggg-
ATGGGTGCGTGGCTGA 39)/G328 (59 acaaagcttctcgagTCAC-
TAAGCACCGATCCCTTG 39).
The LdLPG-2 ORF was amplified from L. donovani LV9
genomic DNA using oligonucleotides G162 (59 actcagatctcatAT-
GAACCATACTCGCTCTGTG 39)/G163 (59 atctggtaccC-
TACTCAGATTTGGAAGTGTC 39), as designed from the
LdLPG-2 sequence (Genbank U26175) and cloned between the
BglII and KpnI sites of pNUS-mREDnD (pNUS-mREDnD-
LdLPG-2).
The LdARF-1 ORF was amplified from L. donovani LV-9
genomic DNA with oligonucleotides G170 (59 gatccatATGGGA-
CAGTGGTTGGCCTCC 39)/G171 (59 gatcggtaccTTGCATG-
GTCGCAGAGATGTTG 39), as designed from the LdARF-1
sequence (Genbank AY157971) and cloned into the vector pNUS-
mRedcD between NdeI and KpnI (pNUS-LdARF-1-mRednD).
The TbGRIP domain (nt 1284–1842, Genbank BK000167=
Tb11.02.5040, GeneDB http://www.genedb.org/) [53] was PCR-
amplified from T. brucei TREU 927 genomic DNA with primers
G213 (59 gatcagatctAGCTCTTTAGTTTCGCCCGATG 39)/
G214 (59 gatcggtaccTTACTTCAATGGGGGACACTG 39); the
BglII/KpnI restricted product was subsequently inserted into the
pNUS-mREDnD digested with the same enzymes (pNUS-
mREDnD-TbGRIP). The homologous region (LdGRIP) of the L.
donovani orthologue (LdpGRIP-1) was PCR-amplified from L.
donovani LV9 genomic DNA with primers G273 (59 gatcca-
tATGTTGAAGCGTGCATCGACTCAAG 39)/G274 (59
gatcggtaccGTGAAATCGAGGGCATCG 39), as designed from
nt 3421-4002 of LinJ11.0070 (GeneDB http://www.genedb.org/),
and cloned between the NdeI and KpnI sites of pNUS-EYFPcD
(pNUS-EYFPcD-LdGRIP). The complete ORF of the L. donovani
LV9 orthologue of L. infantum LinJ34.3660 (GeneDB http://www.
genedb.org/), LdpGRIP-2, was PCR-amplified with G290 (59
ttcagatctcatATGAGCTCTACGGCTAATCG 39)/G291 (59 ttca-
gatctTCATTGCAGCATAGCCTTGG 39) and cloned into the
BglII site of pNUS-mREDnD (pNUS-mREDnD-LdpGRIP-2).
The L. mexicana Dolichol-Phosphate-Mannose Synthase (DPMS)
[69] was PCR-amplified from its cDNA (kind gift of Dr M.
McConville) with primers G293 (59 ctcagatctcatATGCAG-
TACTCCATTATCGTT 39)/G294 (59 ctcggtaccCTAGAA-
GAGGGAATGGTAGAG 39) and cloned between the BglII and
KpnI sites of pNUS-mREDnD (pNUS-mREDnD-LmxDPMS).
L. amazonensis transformation and fluorescence
microscopy
L. amazonensis promastigotes were electroporated and transfor-
mants selected as described [58] with 50 mg/ml G-418 (Life
Technologies), 50 mg/ml hygromycin (Euromedex) or 10 mg/ml
blasticidin (InvivoGen). At least two independent electroporations
were done for each construct.
Immunofluorescence was done as described [58]. Briefly, cells
were spread onto poly-L-Lysine-treated coverslips and fixed for
1 hour with 2% paraformaldehyde at 24uC. The antisera used
were the rabbit anti-LdARL-1 C-terminus (1/1000 dilution), the
rabbit anti-TbVP1 (1/1000 dilution) and the rabbit anti-TbCla-
thrin heavy chain (1/100 dilution). For the latter, an additional cell
permeabilisation step (10 min with 0,1% Triton X-100) was done
after fixation. Secondary antibodies (Molecular Probes) were
FITC-conjugated goat anti-rabbit IgG (10 mg/ml) for LdARL-1 or
Texas Red-conjugated goat anti-rabbit IgG (20 mg/ml) for TbVP-
1 and TbClathrin. DNA was stained by adding 10 mg/ml DAPI in
the last 5 min incubation with the secondary antibody. Coverslips
were washed and mounted on microcope slides with Mowiol [58].
For GFP or mRed fusion proteins, the cells were washed
immediately after paraformaldehyde fixation and mounted.
For endocytosis monitoring, cells (10
7/ml) were incubated in
culture medium with 10% FCS and 2 mg/ml FM4-64FX
(Molecular Probes) for 15 min at 24uC in the dark, harvested,
resuspended in fresh medium, and incubated for various times at
24uC. After two cold PBS washes, cells were spread onto
coverslips, fixed 15 min at 4uC with 4% paraformaldehyde,
washed and mounted.
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cells were washed twice with RPMI-1640 medium plus 1% goat
serum and incubated in RPMI-1640 plus 50 mg/ml biotin-labelled
Concanavalin A (Sigma) for 30 min at 24uC. After two PBS
washes, cells were fixed for 1 hour at room temperature with 2%
paraformaldehyde and further incubated for 1 hour with 10 mg/
ml Texas-Red-Streptavidine conjugate (Molecular Probes).
For acidocalcisomal pyrophosphate staining [50], cells were
washed twice in 116 mM NaCl, 5 mM KCl, 0.8 mM MgSO4,
5.5 mM glucose, 50 mM K-Hepes, pH 7.4, and incubated for
10 min at 30uC in PBS with 10 mg/ml DAPI. Cells were spread on
coverslips by centrifugation and observed alive quickly thereafter.
Observations were done with an Axioplan 2 Zeiss fluorescence
microscope and a 1006 oil lens. Images were acquired with a
Princeton Instruments camera and analysed with Metaview
TM
(Universal Imaging).
Electron microscopy
Electron microscopy was done as described [70] with slight
modifications. 40 ml of exponentially growing pNUS-LdARL-1-
GFP-transformed L. amazonensis promastigotes were collected by
centrifugation, washed in PBS, fixed, dehydrated and embedded in
LR Gold resin. Ultra-thin sections were cut, neutralised in glycine,
blocked and incubated in anti-LdARL-1 rabbit serum diluted 1:5 in
0.5% Tween-20, 0.1% BSA in PBS for 2 h. Sections were washed,
incubated in anti-rabbit IgG-10 nm gold 1:30 in 0.5% Tween-20,
0.1% BSA in PBS and processed as described [70].
Supporting Information
Figure S1 The ARL-1 chromosomal region in trypanosomatids.
Genomic map compiled from the Gene DB Parasite Genome
database (GeneDB http://www.genedb.org/) [1,2,71,72]. L.
major LmARL-1: LmjF17.0070; L. infantum LinfARL-1:
LinJ17.0080; L. brasiliensis LbrARL-1: LbrM17_V2.0080; T.
brucei TbARL-1: Tb927.7.6230, previously Tb07.2F2.550, an-
notated as TbARF-3); T. cruzi TcARL-1: two entries:
Tc00.1047053506513.60 and Tc00.1047053508919.60. The gen-
eral organisation is conserved downstream of the ARL-1 ORF,
while on the upstream side, several successive insertions and gene
duplications occurred in Leishmania (L. brasiliensis.L. major.L.
infantum) compared to the trypanosomes.
Found at: doi:10.1371/journal.pone.0001620.s001 (13.55 MB
TIF)
Figure S2 Growth of L. amazonensis strains and SAP activity in
the supernatant. Cells. BA125 parental strain, cyan. Promastigotes
transformed with pTEX-LdARL-1, brown; pTEX-LdARL-1/G2A,
yellow; pTEX-LdARL-1/Q74L, light green; pTEX-LdARL-1/
T34N, blue; pTEX-LdARL-1/T51N, orange; pNUS-LdARL-1-
GFP,darkgreen. Toppanel:Growth ofparentaland transformed L.
amazonensis promastigotes. Cells were seeded at a density of 2.5 106
cells/ml and counted for the 5 following days; the mean of 2–5
different experiments is indicated with the standard deviation. The
maximal cell density appeared a bit lower for some clones, it is not
known if these changes are significant. In fact, the level of trangenes
expression cannot be accurately controlled; fluorescence microscopy
observations revealed that there are variations from cell to cell, from
clone to clone or within the same clone after different periods of
culture; a more reliable observation might be made with integrated
transgene after homologous recombination but it is not known if the
experiment is possible at all. Bottom panel: Secreted acid
phosphatase (SAP) activity in the culture supernatant. The enzyme
activity was determined as in [58] 2–5 days after seeding, and is
expressedinnmolesofPNPPhydrolyzedperminandmlofmedium.
The complete experiment was done once.
Found at: doi:10.1371/journal.pone.0001620.s002 (9.90 MB TIF)
Figure S3 Interactions of Threonines with GTP and GDP.
ARF-6 and ARL-1 belong to the same subfamily of ras proteins
and their GTP binding sites are well conserved (Fig 1). The
structures of two ARL-1 orthologues, the S. cerevisiae ScARL-1/
GDP [73] and the human HsARL-1/GTP [74,75], have been
determined. Using the software Swiss-PdbViewer/DeepView for
OSX v3.9b1 (http://ca.expasy.org/spdbv/), and the structures of
ScARL-1/GDP (Panel A) and HsARL-1/GTP (Panel B), the
threonines interacting with the GDP (Panel A) or GTP (Panel B)
were selected without modifying their relative positions. Electron
density and H-bonds (Green) were emphasised. N=blue, O=red,
C=white, H=cyan, P=orange. Similarly to Threonine T27 of
HsARF-6, the equivalent threonines T32 of ScARL-1 (Panel A)
and T31 of HsARL-1 (Panel B) interact via H-bonds with the a
and b phosphorus of GDP (Panel A) and GTP (Panel B).
Conversely, like Threonine T44 of HsARF-6, the equivalent
Threonine T49 of ScARL-1 (Panel A) does not interact with GDP
but the equivalent Threonine T48 of HsARL-1 (Panel B) does
interact with GTP. The neighbouring sequences are conserved for
all ARL-1 proteins, including LdARL-1 (Fig 1); one might
relatively safely predict that the mutant proteins LdARL-1/
T34N, ScARL-1/T32N, and HsARL-1/T31N (equivalent to
HsARF-6/T27N) lose significantly their affinity not only for GTP
but also for GDP, so that these proteins are « empty ». Similarly,
the mutations T44N of HsARF-6, T49N of ScARL-1, T48N of
HsARL-1 and T51N of LdARL-1 impair the binding of GTP but
not GDP, leading to a « GDP-blocked form ».
Found at: doi:10.1371/journal.pone.0001620.s003 (6.70 MB TIF)
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